JERASH HOLDINGS US INC (JRSH)

US47632P1012 - Common Stock

4.1  -0.09 (-2.15%)


Fundamental Rating

5

Taking everything into account, JRSH scores 5 out of 10 in our fundamental rating. JRSH was compared to 49 industry peers in the Textiles, Apparel & Luxury Goods industry. JRSH has a great financial health rating, but its profitability evaluates not so good. JRSH has a correct valuation and a medium growth rate.




Profitability

Profitability Rating

1

JRSH has a Piotroski-F score of 4.00. This indicates an average health and profitability for JRSH.
JRSH's Return On Assets of 4.69% is worse than the rest of the industry. The industry average Return On Assets is 9.40%.

JRSH has a Return On Equity of 6.01%. This is below the industry average of 18.62%. 80% of the industry peers outperform JRSH.
JRSH has a Profit Margin of 2.94%. This is below the industry average of 8.25%.
VS Industry

ROA (4.69%) VS Industry: 37% outperformed.

0.85
20.22

ROE (6.01%) VS Industry: 20% outperformed.

1.56
77.18

Profit Margin (2.94%) VS Industry: 24% outperformed.

1.02
16.33

Valuation

Valuation Rating

6

With a Forward Price/Earnings Ratio of 6.43, the valuation of JRSH can be described as cheap.
With a price book ratio of 0.71, JRSH is valued rather cheaply.
When comparing the price book ratio of JRSH to the average industry price book ratio of 2.27, JRSH is valued rather cheaply.

Compared to an average Enterprise Value to EBITDA ratio of 8.80, JRSH is valued rather cheaply. On top of this, JRSH has a better ratio than 100% of the companies listed in the same industry.
With a Price/Earnings Ratio of 12.06, JRSH is valued correctly.
Compared to an average industry Price/Earning Ratio of 10.71, JRSH is valued in line with its industry peers.
VS Industry

Price/Earnings (12.06) VS Industry: 50% outperformed.

90.57
5.58

Price/Book (0.71) VS Industry: 73% outperformed.

13.28
0.30

Enterprise Value/ EBITDA (3.09) VS Industry: 100% outperformed.

2,361.49
2.38

Growth

Growth Rating

4

The Earnings Per Share is expected to grow by 10.33% on average over the next 5 years. This is quite good.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Measured over the past 5 years, JRSH shows a quite strong growth in Revenue. The Revenue has been growing by 18.24% on average per year.
JRSH shows a small growth in Revenue. In the last year, the Revenue has grown by 6.65%.

JRSH is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 7.21% yearly.
The earnings per share for JRSH have decreased strongly by -54.67% in the last year.
JRSH shows a very negative growth in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -11.41% yearly.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-11.41% 2.58% -54.67% -42.25% -3.18% 4.46% 10.33%
Revenue18.24% 19.04% 6.65% -0.85% 2.8% 5.39% 7.21%

Health

Health Rating

8

A Current Ratio of 3.49 indicates that JRSH has no problem at all paying its short term obligations.
The Current Ratio of JRSH is much better than the industry average of 2.59.
A Quick Ratio of 2.08 indicates that JRSH has no problem at all paying its short term obligations.
The Quick Ratio of JRSH is much better than the industry average of 1.25.

When comparing the Debt to Equity Ratio of 0.00 to an average industry Debt to Equity of 0.44, JRSH is way less dependent on financing that its industry peers.
JRSH has an Altman-Z score of 4.75. This indicates that JRSH is financially healthy and little risk of bankruptcy at the moment.
JRSH has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.85. JRSH has a better score than 84% of its industry peers.
JRSH has a Piotroski-F score of 4.00. This indicates an average health and profitability for JRSH.
VS Industry

Debt/Equity (0) VS Industry: 75% outperformed.

10.57
0.00

Quick Ratio (2.08) VS Industry: 77% outperformed.

0.39
4.33

Current Ratio (3.49) VS Industry: 77% outperformed.

1.16
7.29

Altman-Z (4.75) VS Industry: 84% outperformed.

-3.07
13.86

Dividend

Dividend Rating

7

With a Yearly Dividend Yield of 4.52%, JRSH is a good candidate for dividend investing.
JRSH's Dividend Yield is a higher than the industry average which is at 2.80.
Compared to an average S&P500 Dividend Yield of 2.72, JRSH pays a better dividend.
On average, the dividend of JRSH grows each year by 25.99%, which is quite nice.

JRSH has been paying a dividend for over 5 years, so it has already some track record.
58.09% of the earnings are spent on dividend by JRSH. This is a bit on the high side, but may be sustainable.
The Dividend Rate of JRSH has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (4.52%) VS Industry: 72% outperformed.

0.17
6.83

JERASH HOLDINGS US INC

NASDAQ:JRSH (6/1/2023, 2:54:14 PM)

4.1

-0.09 (-2.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-13 2023-02-13/bmo
Earnings (Next)06-21 2023-06-21/bmo
Inst Owners3.33%
Inst Owner Change11.97%
Ins Owners11.77%
Ins Owner Change19.66%
Market Cap50.75M
Analysts82.5
Price Target7.65 (86.59%)
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Dividend Growth(5Y)25.99%
DP58.09%
Div Incr YearsN/A
Div Non Decr Years4
Ex-Date06-01 2023-06-01 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-25.75%
Min EPS beat(2)-27.76%
Max EPS beat(2)-23.75%
EPS beat(4)1
Avg EPS beat(4)-39.98%
Min EPS beat(4)-114.01%
Max EPS beat(4)5.58%
Revenue beat(2)1
Avg Revenue beat(2)5.97%
Min Revenue beat(2)-12.12%
Max Revenue beat(2)24.07%
Revenue beat(4)2
Avg Revenue beat(4)2.09%
Min Revenue beat(4)-12.12%
Max Revenue beat(4)24.07%
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.57%
Valuation
Industry RankSector Rank
PE 12.06
Fwd PE 6.43
P/S 0.35
P/FCF N/A
P/OCF 11.95
P/B 0.71
P/tB 0.72
EV/EBITDA 3.09
EPS(TTM)0.34
EY8.29%
EPS(NY)0.64
Fwd EY15.55%
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)0.34
OCFY8.37%
SpS11.73
BVpS5.74
TBVpS5.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.69%
ROE 6.01%
ROIC 6.35%
ROICexc 9.36%
ROICexgc 9.45%
OM 4.43%
PM 2.94%
GM 16.54%
ROA(3y)8.18%
ROA(5y)11.45%
ROE(3y)10.23%
ROE(5y)14.35%
ROIC(3y)9.44%
ROIC(5y)12.43%
ROICexc(3y)27.46%
ROICexc(5y)23.24%
ROICexgc(3y)27.78%
ROICexgc(5y)23.44%
ROICexcg growth 3Y63.36%
ROICexcg growth 5Y1.72%
ROICexc growth 3Y62.01%
ROICexc growth 5Y1.22%
OM growth 3Y-0.7%
OM growth 5Y-15.76%
PM growth 3Y-2.79%
PM growth 5Y-20.35%
GM growth 3Y-4.8%
GM growth 5Y-5.14%
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.5
Cap/Depr 356.51%
Profit Quality N/A
Current Ratio 3.49
Quick Ratio 2.08
Altman-Z 4.75
F-Score4
WACC8.89%
ROIC/WACC1.06
Cap/Depr(3y)166.8%
Cap/Depr(5y)127.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-54.67%
EPS 3Y2.58%
EPS 5Y-11.41%
EPS growth Q2Q-46.15%
EPS Next Y-42.25%
EPS Next 2Y-3.18%
EPS Next 3Y4.46%
EPS Next 5Y10.33%
Revenue growth 1Y6.65%
Revenue growth 3Y19.04%
Revenue growth 5Y18.24%
Revenue growth Q2Q16.87%
Revenue Next Year-0.85%
Revenue Next 2Y2.8%
Revenue Next 3Y5.39%
Revenue Next 5Y7.21%
EBIT growth 1Y-43.77%
EBIT growth 3Y18.21%
EBIT growth 5Y-0.4%
EBIT Next Year-20.3%
EBIT Next 3Y10.93%
EBIT Next 5Y14.55%
FCF growth 1Y-235.36%
FCF growth 3Y-12.57%
FCF growth 5Y-3.53%
OCF growth 1Y-8.45%
OCF growth 3Y-2.86%
OCF growth 5Y3.14%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA